Burden of Disease in Germany Attributed to Ambient Particulate Matter Pollution : Findings from the Global Burden of Disease Study 2019

Overview

Journal Herz

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 10

PMID 39254857

Authors

Omar Hahad

Jos Lelieveld

Sadeer Al-Kindi

Volker H Schmitt

Lukas Hobohm

Karsten Keller

Martin Roosli

Marin Kuntic

Andreas Daiber

Affiliations

Soon will be listed here.

Abstract

Introduction: Ambient fine particulate matter pollution with a diameter less than 2.5 micrometers (PM) is a significant risk factor for chronic noncommunicable diseases (NCDs), leading to a substantial disease burden, decreased quality of life, and deaths globally. This study aimed to investigate the disease and mortality burdens attributed to PM in Germany in 2019.

Methods: Data from the Global Burden of Disease (GBD) Study 2019 were used to investigate disability-adjusted life-years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and deaths attributed to ambient PM pollution in Germany.

Results: In 2019, ambient PM pollution in Germany was associated with significant health impacts, contributing to 27,040 deaths (2.82% of total deaths), 568,784 DALYs (2.09% of total DALYs), 135,725 YLDs (1.09% of total YLDs), and 433,058 YLLs (2.92% of total YLLs). The analysis further revealed that cardiometabolic and respiratory conditions, such as ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, and diabetes mellitus, were the leading causes of mortality and disease burden associated with ambient PM pollution in Germany from 1990-2019. Comparative assessments between 1990 and 2019 underscored ambient PM as a consistent prominent risk factor, ranking closely with traditional factors like smoking, arterial hypertension, and alcohol use contributing to deaths, DALYs, YLDs, and YLLs.

Conclusion: Ambient PM pollution is one of the major health risk factors contributing significantly to the burden of disease and mortality in Germany, emphasizing the urgent need for targeted interventions to address its substantial contribution to chronic NCDs.

References

Munzel T, Hahad O, Daiber A, Lelieveld J . [Air pollution and cardiovascular diseases]. Herz. 2021; 46(2):120-128. PMC: 7812988. DOI: 10.1007/s00059-020-05016-9. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Lelieveld J, Pozzer A, Poschl U, Fnais M, Haines A, Munzel T . Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective. Cardiovasc Res. 2020; 116(11):1910-1917. PMC: 7449554. DOI: 10.1093/cvr/cvaa025. View

Tobollik M, Kienzler S, Schuster C, Wintermeyer D, Plass D . Burden of Disease Due to Ambient Particulate Matter in Germany-Explaining the Differences in the Available Estimates. Int J Environ Res Public Health. 2022; 19(20). PMC: 9602590. DOI: 10.3390/ijerph192013197. View

Landrigan P, Fuller R, Acosta N, Adeyi O, Arnold R, Basu N . The Lancet Commission on pollution and health. Lancet. 2017; 391(10119):462-512. DOI: 10.1016/S0140-6736(17)32345-0. View

van Donkelaar A, Hammer M, Bindle L, Brauer M, Brook J, Garay M . Monthly Global Estimates of Fine Particulate Matter and Their Uncertainty. Environ Sci Technol. 2021; 55(22):15287-15300. DOI: 10.1021/acs.est.1c05309. View

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

Hahad O, Lelieveld J, Birklein F, Lieb K, Daiber A, Munzel T . Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress. Int J Mol Sci. 2020; 21(12). PMC: 7352229. DOI: 10.3390/ijms21124306. View

10.

Hahad O, Kuntic M, Frenis K, Chowdhury S, Lelieveld J, Lieb K . Physical Activity in Polluted Air-Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review. Antioxidants (Basel). 2021; 10(11). PMC: 8614825. DOI: 10.3390/antiox10111787. View

11.

Pozzer A, Anenberg S, Dey S, Haines A, Lelieveld J, Chowdhury S . Mortality Attributable to Ambient Air Pollution: A Review of Global Estimates. Geohealth. 2023; 7(1):e2022GH000711. PMC: 9828848. DOI: 10.1029/2022GH000711. View

12.

Weichenthal S, Pinault L, Christidis T, Burnett R, Brook J, Chu Y . How low can you go? Air pollution affects mortality at very low levels. Sci Adv. 2022; 8(39):eabo3381. PMC: 9519036. DOI: 10.1126/sciadv.abo3381. View

13.

Lelieveld J, Haines A, Burnett R, Tonne C, Klingmuller K, Munzel T . Air pollution deaths attributable to fossil fuels: observational and modelling study. BMJ. 2023; 383:e077784. PMC: 10686100. DOI: 10.1136/bmj-2023-077784. View

14.

Hahad O, Rajagopalan S, Lelieveld J, Sorensen M, Kuntic M, Daiber A . Noise and Air Pollution as Risk Factors for Hypertension: Part II-Pathophysiologic Insight. Hypertension. 2023; 80(7):1384-1392. PMC: 10330112. DOI: 10.1161/HYPERTENSIONAHA.123.20617. View

15.

Castro A, Kunzli N, de Hoogh K, Kappeler R, Kutlar Joss M, Vienneau D . Mortality attributable to ambient fine particulate matter and nitrogen dioxide in Switzerland in 2019: Use of two-pollutant effect estimates. Environ Res. 2023; 231(Pt 1):116029. DOI: 10.1016/j.envres.2023.116029. View

16.

Castro A, Roosli M, de Hoogh K, Kappeler R, Kutlar Joss M, Vienneau D . Methods Matter: A Comparative Review of Health Risk Assessments for Ambient Air Pollution in Switzerland. Public Health Rev. 2022; 43:1604431. PMC: 9020261. DOI: 10.3389/phrs.2022.1604431. View

17.

Lelieveld J, Klingmuller K, Pozzer A, Poschl U, Fnais M, Daiber A . Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions. Eur Heart J. 2019; 40(20):1590-1596. PMC: 6528157. DOI: 10.1093/eurheartj/ehz135. View

18.

Hahad O . Burden of Disease Due to Air Pollution in Afghanistan-Results from the Global Burden of Disease Study 2019. Int J Environ Res Public Health. 2024; 21(2). PMC: 10888459. DOI: 10.3390/ijerph21020197. View

19.

Plass D, Vos T, Hornberg C, Scheidt-Nave C, Zeeb H, Kramer A . Trends in disease burden in Germany: results, implications and limitations of the Global Burden of Disease study. Dtsch Arztebl Int. 2014; 111(38):629-38. PMC: 4199248. DOI: 10.3238/arztebl.2014.0629. View

20.

Murray C, Ezzati M, Flaxman A, Lim S, Lozano R, Michaud C . GBD 2010: design, definitions, and metrics. Lancet. 2012; 380(9859):2063-6. DOI: 10.1016/S0140-6736(12)61899-6. View